Artificial Intelligence (AI) in Biotechnology Market Size Analysis and Top Companies
The global Artificial Intelligence (AI) in Biotechnology market size is estimated at to hit around USD 22.99 billion by 2033 from USD 4.70 billion in 2024 with a CAGR of 19.29% from 2024 to 2033. The top companies operating in the artificial intelligence (AI) in biotechnology market are AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, Inc., Sanofi, Abbott Laboratories, Biogen, Pfizer, Inc., Novo Nordisk A/S, Amgen, Inc., Merck KGaA, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG and Others.
Market Scope
| Report Coverage |
Details |
| Base Year |
2023 |
| Forecast Period |
2024 to 2034 |
| Largest Market |
North America |
| Fastest Growing Market |
Asia Pacific |
| Segments Covered |
By Offering, By Applications and By Usage |
| Regions Covered |
North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Artificial Intelligence (AI) in Biotechnology Market Companies
- AstraZeneca
- Bristol-Myers Squibb
- Gilead Sciences, Inc.
- Sanofi
- Abbott Laboratories
- Biogen
- Pfizer, Inc.
- Novo Nordisk A/S
- Amgen, Inc.
- Merck KGaA
- Johnson & Johnson Services, Inc.
- F. Hoffmann-La Roche Ltd.
- Novartis AG
Recent Developments
- Green Mountain Biotech and MeNow, Unveil Partnership for AI-Based Advancement of Skincare based on ancient Chinese Medicine in January 2023.
- Insilico Medicine will open a sizeable AI-powered biotech laboratory in Abu Dhabi in 2023.
- Zinc fingers, a new AI-powered biotech technology, offers distinct advantages over CRISPR while developing genomic disease therapies in 2023.
- In 2022, Sanofi formed a collaboration with Exscientia, donating USD 100 million in cash to assist in developing 15 innovative minor molecule applicants in cancer treatment and immunology.
- In 2022, the Utah-based AI biotech Recursion signed a deal with Roche and Genentech to discover molecules employing AI for cancer and neurological indications.
- Bayer and Google Cloud revealed a collaboration in January 2023 to boost Bayer's quantum chemistry equations to initiate early drug discovery through machine learning.
- GSK and Vir Biotechnology collaborated to identify antiviral molecules that cure coronaviruses using artificial intelligence.
We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344
